Skip to content

Effect of the Intensity of Continuous Renal Replacement Therapy

Effect of the Intensity of Continuous Renal Replacement Therapy in Patients With Sepsis and Acute Kidney Injury: Single-center Randomized Clinical Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01251081
Enrollment
280
Registered
2010-12-01
Start date
2004-01-31
Completion date
2010-06-30
Last updated
2010-12-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Optimal Intensity of Renal Replacement Therapy on Sepsis Patients

Keywords

high volume hemofiltration, sepsis, acute kidney injury, survival

Brief summary

In patients with sepsis and AKI, increasing the intensity of renal replacement therapy from 50 mL/kg/h (HVHF) to 85 mL/kg/h (EHVHF)will increase the survival at 28 days and 90 days.

Interventions

OTHERextra high volume hemofiltration

extra high volume hemofiltration (85 mL/kg/h, EHVHF)

high volume hemofiltration (50 mL/kg/h, HVHF)

Sponsors

Zhejiang University
Lead SponsorOTHER

Study design

Primary purpose
TREATMENT

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

met at least one of the following criteria: oliguria (urine output less than 100 mL in a 6 h period and unresponsive to fluid resuscitation), serum potassium concentration more than 6.5 mmol/L, severe acidemia (pH \< 7.2), serum creatinine more than 250 µmol/L, or presence of severe organ edema (e.g. pulmonary edema).

Exclusion criteria

* were presence of a malignant tumor, chronic renal insufficiency (serum creatinine \>133 µmol/L), or receiving any kind of renal replacement therapy before randomization.

Design outcomes

Primary

MeasureTime frameDescription
90 days survivalThe primary study outcome was death from any cause within 90 days. Results were analyzed by Kaplan-Meier survival curves

Secondary

MeasureTime frameDescription
length of stay in the ICU and hospitalSecondary outcomes were length of stay in the ICU and hospital and renal outcome of survivors at 90 days after randomization.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026